Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.39 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.39 |
| ▸ | GRIA3 | P42263 | 2/20 | 0.39 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25183490 | 0.84 | ALDH1A1 (0.41) | SLC9A1GRIN2DGRIN3BGRIA1GRIA2 | |
| SCHEMBL2153695 | 0.78 | SLC9A1 (0.63) | SLC9A1GRIN2DGRIN3BGRIA1GRIA2 | |
| SCHEMBL17870732 | 0.75 | FPR1 (0.42) | SLC9A1GRIN2DGRIN3BGRIA1GRIA2 | |
| SCHEMBL17372113 | 0.70 | KDM4E (0.37) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL7643580 | 0.68 | SLC9A1 (0.58) | SLC9A1 | |
| SCHEMBL24449331 | 0.66 | TDP1 (0.36) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL11248969 | 0.66 | L3MBTL1 (0.54) | MEN1KMT2AAPEX1GLA | |
| SCHEMBL355904 | 0.66 | MPO (0.38) | MEN1KMT2A | |
| SCHEMBL136440 | 0.66 | HDAC6 (0.43) | HDAC6GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL4179886 | 0.65 | TDP1 (0.43) | MEN1KMT2AAPEX1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1581 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257360-A1 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | UNIV OKLAHOMA (US) | 2025-08-14 | — | — | US | claimed |
| EP-4504945-A2 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | The Board of Regents of the University of Oklahoma (US) | 2025-02-12 | — | — | EP | claimed |
| US-12146139-B2 | Oligonucleotide interference treatments of prostate cancer | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2024-11-19 | — | — | US | claimed |
| WO-2023196944-A2 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2023-10-12 | — | — | WO | claimed |
| EP-4058152-A1 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | The Board of Regents of the University of Oklahoma (US) | 2022-09-21 | — | — | EP | claimed |
| US-20220275374-A1 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2022-09-01 | — | — | US | claimed |
| WO-2021097437-A1 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2021-05-20 | — | — | WO | claimed |
| WO-2021072167-A1 | COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-04-15 | — | — | WO | claimed |
| EP-3732187-A1 | UNNATURAL BASE PAIR COMPOSITIONS AND METHODS OF USE | The Scripps Research Institute (US) | 2020-11-04 | — | — | EP | claimed |
| EP-3475295-A1 | NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF | The Scripps Research Institute (US) | 2019-05-01 | — | — | EP | claimed |
| WO-2017223528-A1 | NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-12-28 | — | — | WO | claimed |
| WO-2017106767-A1 | PRODUCTION OF UNNATURAL NUCLEOTIDES USING A CRISPR/CAS9 SYSTEM | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-06-22 | — | — | WO | claimed |
| WO-2016126987-A1 | COMPOSITIONS AND METHODS FOR SYNTHETIC GENE ASSEMBLY | Twist Bioscience Corporation (US) | 2016-08-11 | — | — | WO | claimed |
| WO-2016115168-A1 | INCORPORATION OF UNNATURAL NUCLEOTIDES AND METHODS THEREOF | Synthorx, Inc. (US) | 2016-07-21 | — | — | WO | claimed |
| US-9333218-B2 | MicroRNA compositions and methods related thereto | EMORY UNIVERSITY (US) | 2016-05-10 | — | — | US | claimed |
| WO-1998042723-A9 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | — | 1999-03-04 | — | — | WO | claimed |
| US-5486603-A | Oligonucleotide having enhanced binding affinity | GILEAD SCIENCES, INC. (US) | 1996-01-23 | — | — | US | claimed |
| WO-2026107352-A1 | COMPOSITIONS AND METHODS FOR EFFICIENT NUCLEIC ACID ASSEMBLY AND TISSUE ENGINEERING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-0537299-A4 | OLIGONUCLEOTIDE-TRANSPORT AGENT DISULFIDE CONJUGATES. | GILEAD SCIENCES INC (US) | 1993-02-05 | — | — | EP | disclosed |
| WO-1991014696-A1 | OLIGONUCLEOTIDE-TRANSPORT AGENT DISULFIDE CONJUGATES | GILEAD SCIENCES, INC. (US) | 1991-10-03 | — | — | WO | disclosed |